Side Effects of solifenacin: A Synthesis of Findings from 27 Studies
- Home
- Side Effects of solifenacin
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of solifenacin: A Synthesis of Findings from 27 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Findings
Solifenacin is a medication used to treat overactive bladder, but it has been reported to have several side effects. 4 suggests that clinical data on the use of overactive bladder (OAB) medications are limited by the physician interpretation of adverse effects rather than those that are patient reported. 9 reports a case of a 41-year-old man with spinal cord injury who experienced facial, lip, and tongue edema along with itchy urticaria after taking 5 mg of solifenacin. 7 suggests that while solifenacin may be effective in treating overactive bladder, it can also have other side effects.
Reason for Side Effects
Solifenacin belongs to a class of drugs called muscarinic receptor antagonists. Muscarinic receptors play a role in regulating the contraction of bladder muscles. Solifenacin binds to these receptors, inhibiting bladder muscle contraction and reducing urination frequency. However, muscarinic receptors are present in various tissues besides the bladder, including salivary glands, sweat glands, and the digestive tract. Therefore, solifenacin may bind to muscarinic receptors in other tissues and cause side effects. 12 reports a case of a patient with sialorrhea successfully treated with the combined use of pirenzepine and solifenacin (M1 and M3 muscarinic receptor antagonists, respectively). This suggests that solifenacin may affect muscarinic receptors in the salivary glands, leading to side effects such as sialorrhea.
Common Side Effects
Dry Mouth
Solifenacin can inhibit salivary secretion by binding to muscarinic receptors in the salivary glands, leading to dry mouth as a common side effect. 18 indicates that three newly approved overactive bladder syndrome treating agents, including solifenacin, can affect salivary glands and cause dry mouth. 24 states that solifenacin has greater selectivity for bladder receptors than tolterodine and oxybutynin, resulting in a relatively low incidence of side effects like dry mouth, allowing for the possibility of long-term therapy.
Constipation
Solifenacin can inhibit gastrointestinal motility by binding to muscarinic receptors in the digestive tract, potentially causing constipation as a side effect. 5 suggests that solifenacin can lead to nervous system and gastrointestinal side effects.
Blurred Vision
Solifenacin can inhibit pupillary constriction by binding to muscarinic receptors in the eyes, possibly resulting in blurred vision as a side effect. 5 suggests that solifenacin can lead to nervous system and gastrointestinal side effects.
Dizziness
Solifenacin can disrupt balance by binding to muscarinic receptors in the inner ear, potentially causing dizziness as a side effect. 5 suggests that solifenacin can lead to nervous system and gastrointestinal side effects.
Difficulty Urinating
Solifenacin can inhibit bladder muscle contraction, making urination difficult. 12 reports a case where the combined use of solifenacin and pirenzepine was effective in treating sialorrhea. This suggests that solifenacin can affect muscarinic receptors in the bladder, leading to side effects such as difficulty urinating.
Rapid Heartbeat
Solifenacin can increase heart rate by binding to muscarinic receptors in the heart. 13 indicates that solifenacin has the potential to increase heart rate.
Side Effect Management
Dry Mouth
If you experience dry mouth, it's important to stay hydrated by drinking plenty of fluids. Chewing gum or sucking on candies can also be helpful. 18 indicates that three newly approved overactive bladder syndrome treating agents, including solifenacin, can affect salivary glands and cause dry mouth.
Constipation
If you experience constipation, it's essential to eat a diet rich in fiber and stay hydrated. You may also consider consulting with your doctor to discuss potential laxative options. 5 suggests that solifenacin can lead to nervous system and gastrointestinal side effects.
Blurred Vision
If you experience blurred vision, it's important to consult with your doctor for appropriate treatment. 5 suggests that solifenacin can lead to nervous system and gastrointestinal side effects.
Dizziness
If you experience dizziness, rise slowly from a sitting or lying position and walk slowly. You may also consider talking to your doctor about anti-vertigo medications. 5 suggests that solifenacin can lead to nervous system and gastrointestinal side effects.
Difficulty Urinating
If you experience difficulty urinating, consult with your doctor for appropriate treatment. 12 reports a case where the combined use of solifenacin and pirenzepine was effective in treating sialorrhea. This suggests that solifenacin can affect muscarinic receptors in the bladder, leading to side effects such as difficulty urinating.
Rapid Heartbeat
If you experience a rapid heartbeat, consult with your doctor for appropriate treatment. 13 indicates that solifenacin has the potential to increase heart rate.
Study Comparisons
Commonalities
Several studies have shown that solifenacin is effective in improving overactive bladder symptoms. However, they have also reported side effects such as dry mouth, constipation, blurred vision, and dizziness.
Differences
The types and severity of side effects caused by solifenacin vary across studies. This is likely due to variations in the age, sex, health status, and medications used by participants in different studies. Methodological and data analysis differences may also contribute to these variations.
Real-World Application Considerations
While solifenacin can effectively improve overactive bladder symptoms, it has the potential for side effects. It is crucial to follow your doctor's instructions when using solifenacin and consult with them immediately if you experience any side effects. Individuals with pre-existing conditions such as heart disease, liver disease, or kidney disease should consult with their doctor before taking solifenacin.
Limitations of Current Research
Research on the side effects of solifenacin is still ongoing, and data on long-term side effects are particularly limited. Further research is necessary to determine the long-term safety and efficacy of solifenacin. Additional studies are also needed to investigate how solifenacin affects individuals of various ages, sexes, and health conditions.
Future Research Directions
Although solifenacin is an effective treatment for overactive bladder, it has the potential for side effects. Future research should focus on more comprehensively assessing the safety and efficacy of solifenacin. Delving into the mechanisms behind solifenacin-induced side effects is crucial to develop strategies for mitigating these adverse events.
Conclusion
Solifenacin is an effective medication for overactive bladder but may cause side effects such as dry mouth, constipation, blurred vision, and dizziness. It is crucial to carefully follow your doctor's instructions when using solifenacin and seek immediate medical advice if you experience any side effects.
Benefit Keywords
Risk Keywords
Article Type
Author: KumarShailendra, TiwariVidushi, ChaurasiaDileep K, KumarSudheer, MishraShirish
Language : English
Author: JamilMuhammad Nasir, IrumSadia, IslamEhsan Ul
Language : English
Author: RamanGayathri, TunnicliffeDavid, LaiElise, BennettTrish, CaldwellPatrina
Language : English
Author: SzeChristina, DrangsholtSiri, StoddardMichelina D, SinghZorawar, SansoneStephanie, BhojaniNaeem, ZornKevin, EltermanDean, ChughtaiBilal
Language : English
Author: NichollsConnie, ChyouTe-Yuan, NishtalaPrasad S
Language : English
Author: MoroccoElise, LatackKyle, CiesielskiKatharine, NguyenBrian, DanczChristina
Language : English
Author: MirzaeiMahboubeh, DaneshpajoohAzar, AnvariSeyed Omidreza, DozchizadehSalar, TeimorianMohamad
Language : English
Author: SolimanMohamed G, El-AbdShawky, El-GamalOsama M, RaheemAli Abdel, Abou-RamadanAhmed R, El-AbdAhmed S
Language : English
Author: YounasUmer, ShafiqOmar, MansoorSahibzada Nasir, KhalilMuhammad Tawab
Language : English
Author: FrancoIsrael, HoebekePiet, Baka-OstrowskaMałgorzata, BolongDavid, DaviesLeon N, DahlerEllen, SnijderRobert, StroosmaOtto, VerheggenFrank, NewgreenDonald, BosmanBrigitte, Vande WalleJohan
Language : English
Author: FryerSamantha, NicoaraCezar, DobsonEmily, GriffithsMegan, McAndrewH Fiona, KennySimon E, CorbettHarriet J
Language : English
Author: YamamuraYukie, NonakaManabu
Language : English
Author: CetinelBulent, OnalBulent, GultekinMehmet Hamza, GuzelsoyMuhammed, TuregunFethi Ahmet, DincerMurat
Language : English
Author: KosilovKirill, KuzinaIrina, KuznetsovVladimir, GainullinaYuliya, KosilovaLiliya, KarashchukElena, ProkofyevaAlexandra, LoparevSergay
Language : English
Author: WangChung-Cheng, KuoHann-Chorng
Language : English
Author: AranaAlejandro, MargulisAndrea V, McQuayLisa J, ZiemieckiRyan, BartschJennifer L, RothmanKenneth J, FranksBilly, D'SilvaMilbhor, AppentengKwame, Varas-LorenzoCristina, Perez-GutthannSusana
Language : English
Author: KelleherCon, HakimiZalmai, ZurRichard, SiddiquiEmad, MamanKhaled, AballéaSamuel, NazirJameel, ChappleChris
Language : English
Author: AboulhodaBasma Emad, AliEid Nassar
Language : English
Author: Vecchioli-ScaldazzaCarlo, MorosettiCarolina, MarucciaSerena, CasellatoStefano, RociolaWilma, IllianoEster, GarofaloFrancesco
Language : English
Author: XuYankai, LiuRuihua, LiuChu, CuiYuanshan, GaoZhenli
Language : English
Author: DrakeMarcus J, MacDiarmidScott, ChappleChristopher R, EsenAdil, AthanasiouStavros, Cambronero SantosJavier, MitchesonDavid, HerschornSender, SiddiquiEmad, HuangMoses, StoelzelMatthias
Language : English
Author: TijnagelMarloes J, ScheepeJeroen R, BlokBertil F M
Language : English
Author: RamsaySophie, BolducStéphane
Language : English
Author: GadzhievaZ K, KazilovYu B
Language : Russian
Author: MoysonJ, LegrandF, Vanden BosscheM, QuackelsT, RoumeguèreT
Language : French
Author: AbdelhamidMohamed H, ZayedAhmed S, GhoneimaWaleed E, ElmarakbiAkrm A, El SheemyMohamed S, ArefAhmed, AbdelbaryAhmed, NourHani H
Language : English
Treatment compliance of working persons to high-dose antimuscarinic therapies: a randomized trial.
Author: KosilovKirill Vladimirovich, LoparevSergey, KuzinaIrina, ShakirovaOlga, ZhuravskayaNataliya, LobodenkoAlexandra
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.